Pro-inflammatory effects of cholera toxin: Role of tumor necrosis factor alpha

Toxicon

Volumn 40, Issue 10, 2002, Pages 1487-1494

  Viana, C F G ^a   Melo, D H ^a   Carneiro Filho, B A ^a   Michelin, M A ^b   Brito, G A C ^a   Cunha, F Q ^b   Lima, A A M ^a   Ribeiro, R A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cholera toxin; Inflammation; Tumor necrosis factor; Vibrio cholerae

Indexed keywords

CHOLERA TOXIN; DEXAMETHASONE; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PAW EDEMA; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT;

ANIMALS; CELL MOVEMENT; CHOLERA TOXIN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HINDLIMB; INFLAMMATION; MACROPHAGES, PERITONEAL; MALE; NEUTROPHILS; PENTOXIFYLLINE; RATS; RATS, WISTAR; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 0036802183     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00170-8     Document Type: Article

References (46)

1. Assreuy A., Shibuya M., Martins G., de Souza M., Cavada B., Moreira R., Oliveira J., Ribeiro R., Flores C. Anti-inflammatory effect of glucose-mannose binding lectins isolated from Brazilian beans. Mediators Inflamm. 6:1997;201-210.
2. Blanchard T.G., Lycke N., Czinn S.J., Nedrud J.G. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Immunology. 94:1998;22-27.
3. Brito G.A., Saraiva S.N., Falcao J.L., Vale M.L., Lima A.A., Cunha F.Q., Ribeiro R.A. Dual effect of cAMP on the writhing response in mice. Eur. J. Pharmacol. 416:2001;223-230.
4. Bromander A., Holmgren J., Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:1991;2908-2914.
5. Bromander A.K., Kjerrulf M., Holmgren J., Lycke N. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37:1993;452-458.
6. Choi K.L., Sauder D.N. The role of Langerhans cells and keratinocytes in epidermal immunity. J. Leukoc. Biol. 39:1986;343-358.
7. Chu Z.Y., Rui Y.C. Effects of pentoxifylline and protein kinase C inhibitor on phorbol ester-induced intercellular adhesion molecule-1 expression in brain microvascular endothelial cells. Zhongguo Yaoli Xuebao. 20:1999;741-744.
8. Cox J.C., Coulter A.R. Adjuvants - a classification and review of their modes of action. Vaccine. 15:1997;248-256.
9. Cunha F.Q., Boukili M.A., da Motta J.I., Vargaftig B.B., Ferreira S.H. Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur. J. Pharmacol. 238:1993;47-52.
10. Doherty G.M., Jensen J.C., Alexander H.R., Buresh C.M., Norton J.A. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery. 110:1991;192-198.
11. Elson C.O., Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:1984;2892-2897.
12. Enioutina E.Y., Visic D., Daynes R.A. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine. 18:2000;2753-2767.
13. Fasano A., Baudry B., Pumplin D.W., Wasserman S.S., Tall B.D., Ketley J.M., Kaper J.B. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. USA. 88:1991;5242-5246.
14. Finkelstein R.A., Sobocinski P.Z., Atthasampunna P., Charunmethee P. Pathogenesis of experimental cholera: identification of choleragen (procholeragen A) by disc immunoelectrophoresis and its differentiation from cholera mucinase. J. Immunol. 97:1966;25-33.
15. Finkelstein R.A., Jehl J.J., Goth A. Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs. Proc. Soc. Exp. Biol. Med. 132:1969;835-840.
16. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A., De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30:2000;2394-2403.
17. Han J., Thompson P., Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172:1990;391-394.
18. Hornquist E., Lycke N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23:1993;2136-2143.
19. Irie K., Fujii E., Ishida H., Wada K., Suganuma T., Nishikori T., Yoshioka T., Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin. Br. J. Pharmacol. 133:2001;237-242.
20. Landucci E.C., Antunes E., Donato J.L., Faro R., Hyslop S., Marangoni S., Oliveira B., Cirino G., de Nucci G. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. Br. J. Pharmacol. 114:1995;578-583.
21. Lycke N., Tsuji T., Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:1992;2277-2281.
22. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:1995;4621-4629.
23. Mondino A., Khoruts A., Jenkins M.K. The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA. 93:1996;2245-2252.
24. Moreira A.L., Sampaio E.P., Zmuidzinas A., Frindt P., Smith K.A., Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177:1993;1675-1680.
25. Neuner P., Klosner G., Schauer E., Pourmojib M., Macheiner W., Grunwald C., Knobler R., Schwarz A., Luger T.A., Schwarz T. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology. 83:1994;262-267.
26. Orlandi P.A., Fishman P.H. Orientation of cholera toxin bound to target cells. J. Biol. Chem. 268:1993;17038-17044.
27. Pastores S.M., Hasko G., Vizi E.S., Kvetan V. Cytokine production and its manipulation by vasoactive drugs. New Horiz. 4:1996;252-264.
28. Perretti M., Szabo C., Thiemermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116:1995;2251-2257.
29. Peterson J.W., Reitmeyer J.C., Jackson C.A., Ansari G.A. Protein synthesis is required for cholera toxin-induced stimulation of arachidonic acid metabolism. Biochim. Biophys. Acta. 1092:1991;79-84.
30. Peterson J.W., Lu Y., Duncan S., Cantu J., Chopra A.K. Interactions of intestinal mediators in the mode of action of cholera toxin. J. Med. Microbiol. 41:1994;3-9.
31. Raufman J.P. Cholera. Am. J. Med. 104:1998;386-394.
32. Renz H., Gong J.H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141:1988;2388-2393.
33. Ribeiro R.A., Flores C.A., Cunha F.Q., Ferreira S.H. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology. 73:1991;472-477.
34. Ribeiro R.A., Costa P.F.T., Silva G., Falcao G., Leal R., Melo D., Ferreira F., Morais L.O. Thalidomide (TLD) and pentoxifylline (PTX) prevent the development of chronic cardiomyopathy provoked by doxorubucin (DXR) in rats without inhibiting its antitumoral effect. Moraes M., Brentani R., Bevilacqua R., Proceedings of the 17th International Cancer Congress. 1998;29-33 Monduzzi Editore, Bologna, Italy.
35. Ribeiro R.A., Vale M.L., Ferreira S.H., Cunha F.Q. Analgesic effect of thalidomide on inflammatory pain. Eur. J. Pharmacol. 391:2000;97-103.
36. Sampaio E.P., Sarno E.N., Galilly R., Cohn Z.A., Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med. 173:1991;699-703.
37. Silva T.M., Schleupner M.A., Tacket C.O., Steiner T.S., Kaper J.B., Edelman R., Guerrant R. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae. Infect. Immun. 64:1996;2362-2364.
38. Speelman P., Rabbani G.H., Bukhave K., Rask-Madsen J. Increased jejunal prostaglandin E2 concentrations in patients with acute cholera. Gut. 26:1985;188-193.
39. Standiford T.J., Strieter R.M., Lukacs N.W., Kunkel S.L. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:1995;2222-2229.
40. Sullivan G.W., Carper H.T., Novick W.J. Jr., Mandell G.L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect. Immun. 56:1988;1722-1729.
41. Trucksis M., Galen J.E., Michalski J., Fasano A., Kaper J.B. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA. 90:1993;5267-5271.
42. Ward A., Clissold S.P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 34:1987;50-97.
43. Williams N.A., Hirst T.R., Nashar T.O. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today. 20:1999;95-101.
44. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., McGhee J.R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1993;1309-1320.
45. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc.Natl. Acad. Sci. USA. 94:1997;5267-5272.
46. Yan Z., Yang D.C., Jett M. Cholera toxin induces tumor necrosis factor alpha production in human monocytes. Mol. Cell Biol. Res. Commun. 2:1999;124-130.